Article | March 25, 2021

Will Point Of Care Laboratory Devices Replace Brick And Mortar Labs In Clinical Trials?

Source: Q2 Solutions

By Chuck Drucker , Guy Rachmuth, PhD , Jian Wang, PhD

laboratory scientist data iStock-1209661942

Over the past few years, there has been growth in the use of point of care (POC) testing at investigator sites in clinical trials. For example, devices have been deployed at investigator sites to screen and enroll a patient in a single visit thus helping to reduce screen failure rates via a pre-screening step and providing for results more rapidly than local labs. In each of these cases, the POC laboratory devices were used for screening, but device data was not submitted to regulatory authorities. Instead, samples were sent in parallel to the central laboratory company (central lab), a clinical trial laboratory with globally harmonized laboratory systems and processes. The central lab produced lab reports for the clinical trial investigators and performed the data transfers to sponsors, who need the data for regulatory filings.

The article addresses why sponsors do not typically utilize data from POC laboratory devices in regulatory ļ¬lings, the integration of POC laboratory device data with clinical trial laboratory systems, and whether POC laboratory devices will replace brick and mortar labs.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader